B

Betta Pharmaceuticals Co Ltd
SZSE:300558

Watchlist Manager
Betta Pharmaceuticals Co Ltd
SZSE:300558
Watchlist
Price: 47.74 CNY -1.59%
Market Cap: 20B CNY
Have any thoughts about
Betta Pharmaceuticals Co Ltd?
Write Note

Betta Pharmaceuticals Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Betta Pharmaceuticals Co Ltd
Revenue Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
B
Betta Pharmaceuticals Co Ltd
SZSE:300558
Revenue
ÂĄ2.6B
CAGR 3-Years
8%
CAGR 5-Years
13%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Revenue
ÂĄ10.1B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Revenue
ÂĄ10.7B
CAGR 3-Years
14%
CAGR 5-Years
15%
CAGR 10-Years
22%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Revenue
ÂĄ25.3B
CAGR 3-Years
-5%
CAGR 5-Years
5%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Revenue
ÂĄ39.3B
CAGR 3-Years
3%
CAGR 5-Years
7%
CAGR 10-Years
9%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Revenue
ÂĄ561.9m
CAGR 3-Years
-18%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Betta Pharmaceuticals Co Ltd's Revenue?
Revenue
2.6B CNY

Based on the financial report for Jun 30, 2024, Betta Pharmaceuticals Co Ltd's Revenue amounts to 2.6B CNY.

What is Betta Pharmaceuticals Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
13%

Over the last year, the Revenue growth was 8%. The average annual Revenue growth rates for Betta Pharmaceuticals Co Ltd have been 8% over the past three years , 13% over the past five years .

Back to Top